Eastern Europe/Central Asia advocacy group seeks Global Fund support to push national financing of HIV treatment
A regional network of people living with HIV (EUCO) on 1 May submitted an expression of interest in applying for Global Fund support for advocacy to encourage governments across Eastern Europe and Central Asia to commit to paying for anti-retroviral therapy (ART) and other treatment for HIV.
A motorcycle bouncing along a rutted red dirt road carries a nurse from a public health center near the village of Tai. Clutched in his arms is a box packed with vaccines: a month's supply for his village that sits close to the Liberian border, in Côte d'Ivoire's restive and fractious west.
The Board of the Global Fund on 25 April approved renewal and interim funding of up to $310 million. These announcements do not represent additional resources but rather reflect the country allocations announced on 12 March.
Global Fund partners in eastern and southern Africa have resolved to undertake robust country dialogues and advocate for an increase in domestic financing to boost the fight against HIV, tuberculosis and malaria.
For nearly a decade, China was one of the largest recipients of grants from the Global Fund for its fight against AIDS, TB and malaria. From 2003-2012, more than $805 million was disbursed to support 15 grants, nearly half of which (46%) contributed to prevention, diagnosis and treatment campaigns for TB across the country.
The Global Fund expects Ukraine to do more with less.
The Global Fund is telling countries whose 2014–2016 allocations consisted of only enough money to cover the costs of their existing grants that the money they are receiving has to last until the end of 2017.
The Fund is also telling all countries not to expect to receive any new funding from the 2017-2019 allocation period until the end of 2017.
by Karen Madoyan
by Bernard Rivers
In 2011, the Global Fund faced a crisis of confidence triggered by some negative media articles. In line with the old adage that you should never let a good crisis go to waste, the Fund’s Board sought to address a number of weaknesses, some of which had never been previously discussed.
Bosnia and Herzegovina (BiH) will from December 2015 no longer be eligible for Global Fund financing as it is currently designated an upper middle-income country with low burden of disease.